Always read the label carefully before taking any medications to ensure they're right for you. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) that’s thought to work better for pain ...

Bernstein analyst Florent Cespedes maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £22.90. The company’s shares opened today at p1,443. ...

Shares of GlaxoSmithKline Pharmaceuticals (GSK Pharma) extended their rally for the second consecutive session on Tuesday (February 18), gaining 29% over two days. The stock had hit a 20% upper ...

GlaxoSmithKline share price jumped more than 17% on Tuesday and extended its surge for the third consecutive session. GlaxoSmithKline shares spiked as much as 17.69% to ₹2,744.95 apiece on the ...

Ibuprofen is a type of nonsteroidal anti-inflammatory drug, or NSAID, that is used to relieve pain, fever, and inflammation. It is often recommended for maladies such as back pain, toothache ...

Taking Aleve (naproxen) and Tylenol (acetaminophen) is typically safe. However, this may not be the most effective way to take the medications. Taking Aleve and Tylenol together is typically safe ...

The NHS has issued a warning regarding the use of the widely-used painkiller, ibuprofen, advising individuals to seek an alternative medication if they experience three specific side effects.

Shares of GlaxoSmithKline Pharmaceuticals Ltd. are trading with gains of 20% on Monday, February 17, bucking in trend in a market where most Nifty 50 constituents are trading with losses. GSK Pharma ...

GlaxoSmithKline Pharmaceuticals shares jumped 16% after reporting a five-fold increase in net profit for the third quarter, reaching Rs 229 crore. The strong performance was driven by increased ...

Commenting on the results, Bhushan Akshikar, MD of GlaxoSmithKline Pharmaceuticals, highlighted the company’s strategic initiatives in strengthening its market presence and enhancing access to ...